The Role of Mesenchymal Stem Cells for Hemorrhagic Stroke Management

Authors

  • Mohammad Kurniawan 1. Division of Respirology and Critical Care, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. 2. Stem Cell Medical Technology Integrated Service Installation - Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Telly Kamelia Universitas Indonesia, Faculty of Medicine Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia.
  • Yetty Ramli 1. Stem Cell Medical Technology Integrated Service Installation - Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. 2. Department of Neurology, Faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
  • Reyhan Eddy Yunus Department of Radiology, Faculty of Medicine Universitas Indonesia - Dr.Cipto Mangunkusumo Hospital, Jakarta, Indonesia

Keywords:

Mesenchymal stem cells, Hemorrhagic Stroke, Digital Subtraction Angiography

Abstract

Stroke is ranked as the second-leading cause of death worldwide. As a result, the long-term sequelae of motor and cognitive abnormalities, such as hemiparesis, paralysis, psychomotor, chronic pain, and behavioral symptoms, can delay the patient's full recovery and function in society. In this context, stem cell-based treatment for stroke has been proven effective due to the potential to provide neurorestorative benefits. This study presented a case of a 50-year-old patient admitted to Cipto Mangunkusumo National General Hospital, Jakarta, in 2022 with intracerebral hemorrhage in the left thalamus, surrounding perifocal edema, and left lateral intraventricular hemorrhage. The patient was given mesenchymal stem cells (MSCs) treatment three times through Digital Subtraction Angiography (DSA). The patient achieved good outcomes in terms of body mobility, balance, and voluntary movement of the upper and lower right limbs.

References

Feigin VL, Abate MD, Abate YH, et al. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol [Internet]. 2024 Oct;23(10):973–1003. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1474442224003697

Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018 Apr 1;38(2):208–11.

Kusuma Y, Venketasubramanian N, Kiemas LS, Misbach J, Misbach J. Burden of stroke in Indonesia [Internet]. World Stroke Organization International Journal of Stroke. 2009;4. Available from: http://www.who.int

Venketasubramanian N, Yoon BW, Pandian J, Navarro JC. Stroke epidemiology in South, East, and South-East Asia: A review. Journal of Stroke. Korean Stroke Society; 2017;19:286–94.

Jain M, Gupta S, Rijhwani P, et al. Prevalence of hemorrhagic stroke subtypes, etiological causes, and their association with various stroke-related risk factors: An observational study. Journal of Mahatma Gandhi University of Medical Sciences and Technology. 2023 Sep 16;7(3):78–83.

Yudiarto F, Machfoed M, Darwin A, Ong A, Karyana M, Siswanto. Indonesia stroke registry (S12.003). Neurology. 2014;82(10 Suppl):S12.003.

Singh M, Pandey PK, Bhasin A, Padma MV, Mohanty S. Application of stem cells in stroke: A multifactorial approach. Frontiers in Neuroscience. Frontiers Media S.A.. 2020;14.

Chrostek MR, Fellows EG, Crane AT, Grande AW, Low WC. Efficacy of stem cell-based therapies for stroke. Brain Research. 2019;1722.

Gong YH, Hao SL, Wang BC. Mesenchymal stem cells transplantation in intracerebral hemorrhage: Application and challenges. Frontiers in Cellular Neuroscience. 2021;15.

Stokum JA, Gerzanich V, Simard JM. Molecular pathophysiology of cerebral edema. Journal of Cerebral Blood Flow and Metabolism. 2016;36:513–38.

Rajashekar D, Liang JW. Intracerebral hemorrhage. StatPearl [Internet]. 2024 [cited 2024 Jun 21]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK553103/

Aronowski J, Zhao X. Molecular pathophysiology of cerebral hemorrhage: Secondary brain injury. Stroke. 2011;42:1781–6.

Magid-Bernstein J, Girard R, Polster S, et al. Cerebral hemorrhage: Pathophysiology, treatment, and future directions. Circ Res. 2022 Apr 15;130(8):1204–29.

Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 Guideline for the management of patients with spontaneous intracerebral hemorrhage: A guideline from the American Heart Association/American Stroke Association. Vol. 53. Stroke. Lippincott Williams and Wilkins; 2022. p. E282–361.

Permana AT, Bajamal AH, Parenrengi MA, Suroto NS, Lestari P, Fauzi A Al. Clinical outcome and safety of stem cell therapy for ischemic stroke: A systematic review and meta-analysis. Surgical Neurology International. 2022;13.

Gong YH, Hao SL, Wang BC. Mesenchymal stem cells transplantation in intracerebral hemorrhage: Application and challenges. Frontiers in Cellular Neuroscience. 2021;15.

Meamar R, Dehghani L, Ghasemi M, Khorvash F, Shaygannejad V. Stem cell therapy in stroke: A review literature [Internet]. Vol. 4. Available from: www.ijpm.ir

Putra A. Basic molecular stem cell. Semarang: Unissula Press; 2019.

Xia Y, Zhu J, Yang R, Wang H, Li Y, Fu C. Mesenchymal stem cells in the treatment of spinal cord injury: Mechanisms, current advances, and future challenges. Frontiers in Immunology. 2023;14.

Rosado-de-Castro PH, de Carvalho FG, de Freitas GR, Mendez-Otero R, Pimentel-Coelho PM. Review of preclinical and clinical studies of bone marrow-derived cell therapies for intracerebral hemorrhage. Stem Cells Int. 2016 Sep 6;2016(1).

Kim JT, Youn DH, Kim BJ, Rhim JK, Jeon JP. Recent stem cell research on hemorrhagic stroke: An update. Journal of Korean Neurosurgical Society. 2022;65:161–72.

Zhou H, Zhang H, Yan Z, Xu R. Transplantation of human amniotic mesenchymal stem cells promotes neurological recovery in an intracerebral hemorrhage rat model. Biochem Biophys Res Commun. 2016 Jun 24;475(2):202–8.

Chouaib B, Haack-Sørensen M, Chaubron F, Cuisinier F, Collart-Dutilleul PY. Towards the standardization of mesenchymal stem cell secretome-derived product manufacturing for tissue regeneration. International Journal of Molecular Sciences. 2023;24.

Takamiya S, Kawabori M, Fujimura M. Stem cell therapies for intracerebral hemorrhage: Review of preclinical and clinical studies. Cell Transplantation. 2023;32.

Chen L, Xi H, Huang H, et al. Multiple cell transplantation based on an intraparenchymal approach for patients with chronic phase stroke. Cell Transplant. 2013;22(Supp.1).

Hu Y, Liu N, Zhang P, et al. Preclinical studies of stem cell transplantation in intracerebral hemorrhage: A systemic review and meta-analysis. Molecular Neurobiology. 2016;53:5269–77.

Turnbull MT, Zubair AC, Meschia JF, Freeman WD. Mesenchymal stem cells for hemorrhagic stroke: status of preclinical and clinical research. NPJ Regenerative Medicine. 2019;4.

Jingli Y, Jing W, Saeed Y. Ischemic brain stroke and mesenchymal stem cells: an overview of molecular mechanisms and therapeutic potential. Stem Cells Int. 2022; 2022:5930244. doi: 10.1155/2022/5930244

Zhou L, Zhu H, Bai X, et al. Potential mechanisms and therapeutic targets of mesenchymal stem cell transplantation for ischemic stroke. Stem Cell Res Ther. 2022; 13:195. doi: 10.1186/s13287-022-02876-2

Singh M, Pandey PK, Bhasin A, Padma MV, Mohanty S. Application of stem cells in stroke: a multifactorial approach. Front Neurosci. 2020;14:473. doi: 10.3389/fnins.2020.00473

Zhu J, Xiao Y, Li Z, Han F, Xiao T, Zhang Z, Geng F. Efficacy of surgery combined with autologous bone marrow stromal cell transplantation for treatment of intracerebral hemorrhage. Stem Cells Int. 2015;2015:318269.

Chang Z, Mao G, Sun L, Ao Q, Gu Y, Liu Y. Cell therapy for cerebral hemorrhage: five-year follow-up report. Exp Ther Med. 2016;12(6):3535–40.

Downloads

Published

2025-12-23

How to Cite

Kurniawan, M., Kamelia, T., Ramli, Y., & Yunus, R. E. (2025). The Role of Mesenchymal Stem Cells for Hemorrhagic Stroke Management. Acta Medica Indonesiana, 57(4), 514. Retrieved from http://www.actamedindones.org/index.php/ijim/article/view/2982

Issue

Vol. 57 No. 4 (2025): Acta Medica Indonesiana

Section

CASE REPORT

License

Copyright (c) 2025 Telly Kamelia

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright

The authors who publish in this journal agree to the following requirements:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a  Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.